Identifying Ventricular Arrhythmias and Their Predictors by Applying
  Machine Learning Methods to Electronic Health Records in Patients With
  Hypertrophic Cardiomyopathy(HCM-VAr-Risk Model)
  Clinical risk stratification for sudden cardiac death (SCD) in hypertrophic
cardiomyopathy (HC) employs rules derived from American College of Cardiology
Foundation/American Heart Association (ACCF/AHA) guidelines or the HCM Risk-SCD
model (C-index of 0.69), which utilize a few clinical variables. We assessed
whether data-driven machine learning methods that consider a wider range of
variables can effectively identify HC patients with ventricular arrhythmias
(VAr) that lead to SCD. We scanned the electronic health records of 711 HC
patients for sustained ventricular tachycardia or ventricular fibrillation.
Patients with ventricular tachycardia or ventricular fibrillation (n = 61) were
tagged as VAr cases and the remaining (n = 650) as non-VAr. The 2-sample t test
and information gain criterion were used to identify the most informative
clinical variables that distinguish VAr from non-VAr; patient records were
reduced to include only these variables. Data imbalance stemming from low
number of VAr cases was addressed by applying a combination of over- and
under-sampling strategies.We trained and tested multiple classifiers under this
sampling approach, showing effective classification. We evaluated 93 clinical
variables, of which 22 proved predictive of VAr. The ensemble of logistic
regression and naive Bayes classifiers, trained based on these 22 variables and
corrected for data imbalance, was most effective in separating VAr from non-VAr
cases (sensitivity = 0.73, specificity = 0.76, C-index = 0.83). Our method
(HCM-VAr-Risk Model) identified 12 new predictors of VAr, in addition to 10
established SCD predictors. In conclusion, this is the first application of
machine learning for identifying HC patients with VAr, using clinical
attributes.
